Brief: Zynerba Pharmaceuticals Announces Publication In The Journal Of Neurodevelopmental Disorders Describing The Role Of The Endocannabinoid System And Cannabidiol Therapy In Fragile X Syndrome
11/01/2023 13:39
Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS ANNOUNCES PUBLICATION IN THE
JOURNAL OF
NEURODEVELOPMENTAL DISORDERS DESCRIBING THE ROLE OF THE
ENDOCANNABINOID SYSTEM AND CANNABIDIOL THERAPY IN FRAGILE X
SYNDROME
Source text for Eikon: ID:nGNX9hvDlC
Further company coverage: ZYNE.O
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary